DAWN vs MSFT: Which Stock is Better?
Side-by-side comparison of Day One Biopharmaceuticals Inc and Microsoft Corp in 2026
DAWN
Day One Biopharmaceuticals Inc
$12.11
MSFT
Microsoft Corp
$454.79
Key Metrics Comparison
| Metric | DAWN | MSFT | Winner |
|---|---|---|---|
| Market Cap | $1.24B | $3.38T | MSFT |
| P/E Ratio | N/A | 36.30 | MSFT |
| EPS (TTM) | $N/A | $13.70 | MSFT |
| Revenue Growth | -0.6% | 14.9% | MSFT |
| Gross Margin | 89.4% | 68.8% | DAWN |
Analyze DAWN
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is DAWN or MSFT a better investment?
Comparing DAWN and MSFT: Day One Biopharmaceuticals Inc has a market cap of $1.24B while Microsoft Corp has $3.38T. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between DAWN and MSFT?
DAWN (Day One Biopharmaceuticals Inc) and MSFT (Microsoft Corp) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: DAWN or MSFT?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: DAWN or MSFT?
MSFT has higher revenue growth at 14.9% vs -0.6% for DAWN.
Which company is more profitable: DAWN or MSFT?
Day One Biopharmaceuticals Inc (DAWN) has higher gross margins at 89.4% compared to 68.8% for MSFT.
Which is the larger company: DAWN or MSFT?
Microsoft Corp (MSFT) is larger with a market cap of $3.38T compared to $1.24B for DAWN.
Should I buy DAWN or MSFT in 2026?
Both DAWN and MSFT have investment merit. DAWN trades at $12.11 while MSFT trades at $454.79. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between DAWN and MSFT stock?
Key differences: Market Cap ($1.24B vs $3.38T), P/E Ratio (N/A vs 36.3x), Revenue Growth (-0.6% vs 14.9%), Gross Margin (89.4% vs 68.8%).